Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative oliceridine vs sufentanil for gynecologic surgery incision pain
ChiCTR2400084985Phase 4Not yet recruiting
- Sponsor
- Tianjin Central Hospital of Obstetrics and Gynecology
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in postoperative pain (2 arms), sponsored by Tianjin Central Hospital of Obstetrics and Gynecology. Primary endpoints: Sedation and restlessness score, Agitation score and 2 more. Planned start May 2024; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400084985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400084985.